The Global Health Body Sounds Alert Over Critical Lack of Obesity Medications

Under one in 10 people that would benefit from GLP-1 drugs such as Wegovy have access to them, caution the World Health Organization as it releases its initial guidance on the therapies.

Considering more than one billion people worldwide now classified as obese, it is urging increased and just availability to GLP-1 medication.

Based on forecasts, in excess of 2,000,000,000 could be obese by 2030 unless action is taken.

"The latest guidance acknowledges that obesity is a lifelong illness that can be treated with thorough and continuous care," remarked WHO director-general Tedros Adhanom Ghebreyesus.

Significant expense, constrained manufacturing, and supply-chain constraints are key hurdles to universal availability to the treatments that can aid individuals in losing significant body mass, says the agency.

GLP-1 Therapy Supply Crisis

Even under the current most optimistic scenario, the manufacturing of these medications could only cover around 100 million people – less than 10% of the global need, as stated by the health organization.

The advice calls on nations and manufacturers to increase availability, through approaches like licensing agreements.

The intellectual property rights on a key compound – the core component of a leading brand – is due to expire in several countries in 2026.

How Weight-Loss Injections Operate

GLP-1 drugs imitate a biological compound to delay gastric emptying, suppress the appetite and boost the sense of being full so users reduce food intake.

Individuals commonly start to lose weight in the initial weeks of beginning the once-weekly jabs.

Studies indicates users may see weight return after a year of halting the treatment, when their normal food cravings return.

Being above a healthy weight elevates your chance for experiencing medical conditions, like type 2 diabetes, cardiovascular issues, brain attack, and some malignancies.

Obesity concerns people in countries worldwide and was responsible for millions of deaths worldwide in 2024, as per the WHO.